Pulmonary Infections
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis (NCT01519661) | Novartis Pharmaceuticals | 2012-01-01 |
| Dornase Alfa Therapy for Ventilator Associated Lung Infections in the Neonatal Intensive Care Unit (NICU) (NCT01356147) | Georgetown University | 2011-05-01 |
| Second Open Label Extension to Bridging Study CTBM100C2303 (NCT01069705) | Novartis Pharmaceuticals | 2010-02-12 |
Track Pulmonary Infections automatically
Every clearance here is in the API, with alerts when new ones post.